The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition

Mitsuo Terada1, Aki Ito2, Yuichiro Kikawa3

  • 1Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

PubMed

Insights

The 2022 Japanese Breast Cancer Society guidelines offer updated systemic treatment recommendations. These evidence-based updates focus on efficacy and safety, incorporating findings from Japanese clinical trials.

Area of Science:

  • Oncology
  • Clinical Practice Guidelines
  • Breast Cancer Treatment

Background:

  • The Japanese Breast Cancer Society (JBCS) initiated an update process in 2018.
  • Guidelines are crucial for standardizing breast cancer care.

Purpose of the Study:

  • To present the 2022 edition of the JBCS Clinical Practice Guidelines for systemic breast cancer treatment.
  • To highlight key updates and practice-changing recommendations based on recent evidence.

Main Methods:

  • Systematic reviews (quantitative and qualitative) of evidence were conducted for 33 clinical questions (CQs).
  • Outcomes including efficacy and safety were assessed.
  • Recommendations were finalized through a voting process by committee members.

Main Results:

  • The 2022 guidelines include 12 background questions (BQs), 33 CQs, and 20 future research questions (FRQs).
  • Eight selected CQs represent significant updates, including novel practice-changing information.
  • Recommendations are based on evidence, with a focus on Japanese clinical trials.

Conclusions:

  • The updated guidelines provide current, evidence-based recommendations for systemic breast cancer treatment.
  • These guidelines incorporate recent advancements and trial data, particularly from Japan.
  • The JBCS aims to improve patient outcomes through these updated clinical practice guidelines.

Related Concept Videos

Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
664
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
704
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
365